Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 437

1.

Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB.

J Am Soc Nephrol. 2019 Feb;30(2):346-353. doi: 10.1681/ASN.2018060581. Epub 2019 Jan 24.

PMID:
30679380
2.

Symbiotic organs shaped by distinct modes of genome evolution in cephalopods.

Belcaid M, Casaburi G, McAnulty SJ, Schmidbaur H, Suria AM, Moriano-Gutierrez S, Pankey MS, Oakley TH, Kremer N, Koch EJ, Collins AJ, Nguyen H, Lek S, Goncharenko-Foster I, Minx P, Sodergren E, Weinstock G, Rokhsar DS, McFall-Ngai M, Simakov O, Foster JS, Nyholm SV.

Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3030-3035. doi: 10.1073/pnas.1817322116. Epub 2019 Jan 11.

3.

Growth of the ESKD Population: Progress or Peril?

Collins AJ.

J Am Soc Nephrol. 2019 Jan;30(1):3-4. doi: 10.1681/ASN.2018111135. Epub 2018 Dec 17. No abstract available.

PMID:
30559145
4.

Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project.

Burrows NR, Vassalotti JA, Saydah SH, Stewart R, Gannon M, Chen SC, Li S, Pederson S, Collins AJ, Williams DE.

Am J Nephrol. 2018;48(6):447-455. doi: 10.1159/000495082. Epub 2018 Nov 23.

PMID:
30472707
5.

A Stark Future for the Stark Law?

Collins A, Clark K, George A.

Home Healthc Now. 2018 Nov/Dec;36(6):393. doi: 10.1097/NHH.0000000000000750. No abstract available.

PMID:
30383600
6.

Volume of urea cleared as a therapy dosing guide for more frequent hemodialysis.

Leypoldt JK, Weinhandl ED, Collins AJ.

Hemodial Int. 2019 Jan;23(1):42-49. doi: 10.1111/hdi.12692. Epub 2018 Sep 25.

PMID:
30255600
7.

Ligand-Mediated Biofilm Formation via Enhanced Physical Interaction between a Diguanylate Cyclase and Its Receptor.

Giacalone D, Smith TJ, Collins AJ, Sondermann H, Koziol LJ, O'Toole GA.

MBio. 2018 Jul 10;9(4). pii: e01254-18. doi: 10.1128/mBio.01254-18.

8.

Urgent: Stop Preventable Infections Now.

Collins AJ, Kliger AS.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):663-665. doi: 10.2215/CJN.10790917. Epub 2018 Mar 22. No abstract available.

PMID:
29567859
9.

Readmissions Following a Hospitalization for Cardiovascular Events in Dialysis Patients: A Retrospective Cohort Study.

Wetmore JB, Molony JT, Liu J, Peng Y, Herzog CA, Collins AJ, Gilbertson DT.

J Am Heart Assoc. 2018 Feb 13;7(4). pii: e007231. doi: 10.1161/JAHA.117.007231.

10.

A Multimodal Strategy Used by a Large c-di-GMP Network.

Dahlstrom KM, Collins AJ, Doing G, Taroni JN, Gauvin TJ, Greene CS, Hogan DA, O'Toole GA.

J Bacteriol. 2018 Mar 26;200(8). pii: e00703-17. doi: 10.1128/JB.00703-17. Print 2018 Apr 15.

11.

Relative risk of home hemodialysis attrition in patients using a telehealth platform.

Weinhandl ED, Collins AJ.

Hemodial Int. 2018 Jul;22(3):318-327. doi: 10.1111/hdi.12621. Epub 2017 Dec 6.

PMID:
29210164
12.

Insights From the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients.

Wetmore JB, Li S, Molony JT, Guo H, Herzog CA, Gilbertson DT, Peng Y, Collins AJ.

Am J Kidney Dis. 2018 Jan;71(1):123-132. doi: 10.1053/j.ajkd.2017.08.023. Epub 2017 Nov 20.

PMID:
29162336
13.

Population representation among anatomical donors and the implication for medical student education.

Collins AJ, Smith W, Giannaris EL, Orvek E, Lazar P, Carney JK, Gilroy AM, Rosen MP.

Clin Anat. 2018 Mar;31(2):250-258. doi: 10.1002/ca.23013. Epub 2017 Dec 6.

PMID:
29127734
14.

Long Overdue Need to Reduce Infections with Hemodialysis.

Kliger AS, Collins AJ.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1728-1729. doi: 10.2215/CJN.09280817. Epub 2017 Oct 3. No abstract available.

15.

Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.

Collins AJ, Pitt B, Reaven N, Funk S, McGaughey K, Wilson D, Bushinsky DA.

Am J Nephrol. 2017;46(3):213-221. doi: 10.1159/000479802. Epub 2017 Sep 2.

16.

Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US.

Mues KE, Liede A, Liu J, Wetmore JB, Zaha R, Bradbury BD, Collins AJ, Gilbertson DT.

Clin Epidemiol. 2017 May 9;9:267-277. doi: 10.2147/CLEP.S105613. eCollection 2017. Review.

17.

Use of prophylactic growth factors and antimicrobials in elderly patients with cancer: a review of the Medicare database.

Sosa R, Li S, Molony JT, Liu J, Stryker S, Collins AJ.

Support Care Cancer. 2017 Oct;25(10):3123-3132. doi: 10.1007/s00520-017-3720-x. Epub 2017 Apr 29.

PMID:
28456908
18.

Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost.

Solid CA, Peter SA, Natwick T, Guo H, Collins AJ, Arduino JM.

Nephron. 2017;136(2):54-61. doi: 10.1159/000454684. Epub 2017 Feb 18.

PMID:
28214902
19.

Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer.

Li S, Liu J, Virnig BA, Collins AJ.

Breast Cancer Res Treat. 2017 Feb;161(3):515-524. doi: 10.1007/s10549-016-4074-7. Epub 2016 Dec 8.

PMID:
27933451
20.

Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysis.

Wetmore JB, Liu J, Dluzniewski PJ, Ishani A, Block GA, Collins AJ.

BMC Surg. 2016 Nov 29;16(1):77.

21.

Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Jha V, Arici M, Collins AJ, Garcia-Garcia G, Hemmelgarn BR, Jafar TH, Pecoits-Filho R, Sola L, Swanepoel CR, Tchokhonelidze I, Wang AY, Kasiske BL, Wheeler DC, Spasovski G; Conference Participants.

Kidney Int. 2016 Dec;90(6):1164-1174. doi: 10.1016/j.kint.2016.09.009.

22.

Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis.

Block GA, Yusuf AA, Danese MD, Wirtz HS, Hu Y, Do TP, Cooper K, Gilbertson DT, Bradbury BD, Collins AJ.

BMC Nephrol. 2016 Nov 4;17(1):166.

23.

Intensive Hemodialysis: Time to Give the Therapy Greater Consideration.

Collins AJ, Chan CT.

Am J Kidney Dis. 2016 Nov;68(5 Suppl 1):S1-S4. doi: 10.1053/j.ajkd.2016.05.027. No abstract available.

PMID:
27772638
24.

Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.

Heussler GE, Miller JL, Price CE, Collins AJ, O'Toole GA.

J Bacteriol. 2016 Oct 21;198(22):3080-3090. Print 2016 Nov 15.

25.

The US Renal Data System "Pie Chart of Death".

Herzog CA, Gilbertson DT, Collins AJ.

Am J Kidney Dis. 2016 Dec;68(6):986. doi: 10.1053/j.ajkd.2016.08.015. Epub 2016 Sep 20. No abstract available.

PMID:
27663038
26.

The Healthy People 2020 Objectives for Kidney Disease: How Far Have We Come, and Where Do We Need to Go?

Wetmore JB, Liu J, Li S, Hu Y, Peng Y, Gilbertson DT, Collins AJ.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):200-209. doi: 10.2215/CJN.04210416. Epub 2016 Aug 30.

27.

The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.

Wetmore JB, Guo H, Liu J, Collins AJ, Gilbertson DT.

Kidney Int. 2016 Oct;90(4):853-60. doi: 10.1016/j.kint.2016.04.026. Epub 2016 Jul 15.

PMID:
27425855
28.

Geovariation in Fracture Risk among Patients Receiving Hemodialysis.

Wetmore JB, Liu J, Wirtz HS, Gilbertson DT, Cooper K, Nieman KM, Collins AJ, Bradbury BD.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1413-21. doi: 10.2215/CJN.11651115. Epub 2016 Jun 7.

29.

Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care.

Wetmore JB, Tzivelekis S, Collins AJ, Solid CA.

BMC Nephrol. 2016 May 26;17(1):53. doi: 10.1186/s12882-016-0267-x.

30.

Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.

Moyer BJ, Rojas IY, Kerley-Hamilton JS, Hazlett HF, Nemani KV, Trask HW, West RJ, Lupien LE, Collins AJ, Ringelberg CS, Gimi B, Kinlaw WB 3rd, Tomlinson CR.

Toxicol Appl Pharmacol. 2016 Jun 1;300:13-24. doi: 10.1016/j.taap.2016.03.011. Epub 2016 Mar 25.

31.

Improving Outcomes in Patients Receiving Dialysis: The Peer Kidney Care Initiative.

Wetmore JB, Gilbertson DT, Liu J, Collins AJ.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1297-304. doi: 10.2215/CJN.12981215. Epub 2016 Mar 22.

32.

Effects of Epoetin Alfa Titration Practices, Implemented After Changes to Product Labeling, on Hemoglobin Levels, Transfusion Use, and Hospitalization Rates.

Molony JT, Monda KL, Li S, Beaubrun AC, Gilbertson DT, Bradbury BD, Collins AJ.

Am J Kidney Dis. 2016 Aug;68(2):266-276. doi: 10.1053/j.ajkd.2016.02.038. Epub 2016 Mar 12.

PMID:
26980607
33.

Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.

Chertow GM, Liu J, Monda KL, Gilbertson DT, Brookhart MA, Beaubrun AC, Winkelmayer WC, Pollock A, Herzog CA, Ashfaq A, Sturmer T, Rothman KJ, Bradbury BD, Collins AJ.

J Am Soc Nephrol. 2016 Oct;27(10):3129-3138. Epub 2016 Feb 25.

34.

Co-trending of parathyroid hormone and phosphate in patients receiving hemodialysis.

Block G, Do TP, Collins AJ, Cooper KC, Bradbury BD.

Clin Nephrol. 2016 Mar;85(3):142-51. doi: 10.5414/CN108629.

PMID:
26784912
35.

Shaping Public Health Initiatives in Kidney Diseases: The Peer Kidney Care Initiative.

Wetmore JB, Gilbertson DT, Collins AJ.

Blood Purif. 2016;41(1-3):151-8. doi: 10.1159/000441316. Epub 2016 Jan 15. Review.

36.

Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Macdougall IC, Bircher AJ, Eckardt KU, Obrador GT, Pollock CA, Stenvinkel P, Swinkels DW, Wanner C, Weiss G, Chertow GM; Conference Participants.

Kidney Int. 2016 Jan;89(1):28-39. doi: 10.1016/j.kint.2015.10.002.

37.

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K; CKD Prognosis Consortium.

JAMA. 2016 Jan 12;315(2):164-74. doi: 10.1001/jama.2015.18202. Erratum in: JAMA. 2016 Feb 23;315(8):822.

38.

Contribution of Physical Interactions to Signaling Specificity between a Diguanylate Cyclase and Its Effector.

Dahlstrom KM, Giglio KM, Collins AJ, Sondermann H, O'Toole GA.

MBio. 2015 Dec 15;6(6):e01978-15. doi: 10.1128/mBio.01978-15.

39.

Patient characteristics, disease burden, and medication use in stage 4 - 5 chronic kidney disease patients.

Wetmore JB, Peng Y, Jackson S, Matlon TJ, Collins AJ, Gilbertson DT.

Clin Nephrol. 2016 Feb;85(2):101-11. doi: 10.5414/CN108626.

PMID:
26636331
40.

Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.

Gilbertson DT, Bradbury BD, Wetmore JB, Weinhandl ED, Monda KL, Liu J, Brookhart MA, Gustafson SK, Roberts T, Collins AJ, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):269-77. doi: 10.1002/pds.3922. Epub 2015 Nov 26.

PMID:
26608680
41.

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study.

Weinhandl ED, Gilbertson DT, Collins AJ.

Am J Kidney Dis. 2016 Jan;67(1):98-110. doi: 10.1053/j.ajkd.2015.07.014. Epub 2015 Aug 28.

42.

Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.

Wetmore JB, Liu J, Do TP, Lowe KA, Ishani A, Bradbury BD, Block GA, Collins AJ.

Nephrol Dial Transplant. 2016 Jan;31(1):103-11. doi: 10.1093/ndt/gfv291. Epub 2015 Aug 19.

PMID:
26292694
43.

Meeting the World's Need for Maintenance Dialysis.

Wetmore JB, Collins AJ.

J Am Soc Nephrol. 2015 Nov;26(11):2601-3. doi: 10.1681/ASN.2015060660. Epub 2015 Jul 24. No abstract available.

44.

Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis.

Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, Bradbury BD, Collins AJ, Gilbertson DT.

Am J Nephrol. 2015;41(4-5):354-61. doi: 10.1159/000431335. Epub 2015 Jun 17.

PMID:
26107376
45.

United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease.

Collins AJ, Foley RN, Gilbertson DT, Chen SC.

Kidney Int Suppl (2011). 2015 Jun;5(1):2-7.

46.

Sharing knowledge on dialysis registries worldwide.

Iseki K, Collins AJ.

Kidney Int Suppl (2011). 2015 Jun;5(1):1. No abstract available.

47.

Peer kidney care initiative 2014 report: dialysis care and outcomes in the United States.

Weinhandl E, Constantini E, Everson S, Gilbertson D, Li S, Solid C, Anger M, Bhat JG, DeOreo P, Krishnan M, Nissenson A, Johnson D, Ikizler TA, Maddux F, Sadler J, Tyshler L, Parker T 3rd, Schiller B, Smith B, Lindenfeld S, Collins AJ.

Am J Kidney Dis. 2015 Jun;65(6 Suppl 1):Svi, S1-140. doi: 10.1053/j.ajkd.2015.03.021. No abstract available.

PMID:
26003780
48.

Conceptualizing intragroup and intergroup dynamics within a controlled crowd evacuation.

Elzie T, Frydenlund E, Collins AJ, Robinson RM.

J Emerg Manag. 2015 Mar-Apr;13(2):109-20. doi: 10.5055/jem.2015.0224.

PMID:
25902294
49.

Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study.

St Peter WL, Yusuf AA, Do T, Lowe KA, Liu J, Nieman KM, Bradbury BD, Collins AJ.

BMC Nephrol. 2015 Mar 31;16:41. doi: 10.1186/s12882-015-0030-8.

50.

One-year mortality rates in US children with end-stage renal disease.

Chavers BM, Molony JT, Solid CA, Rheault MN, Collins AJ.

Am J Nephrol. 2015;41(2):121-8. doi: 10.1159/000380828. Epub 2015 Mar 7.

Supplemental Content

Loading ...
Support Center